dauricine has been researched along with Alzheimer Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Deng, L; Li, M; Pu, Z; Wang, K; Wang, L | 1 |
Chen, L; Chen, W; Luo, B; Mo, J; Peng, C; Wang, K; Wang, L | 1 |
Chen, W; Li, M; Luo, Y; Ma, S; Pu, Z; Shang, L; Wang, L | 1 |
3 other study(ies) available for dauricine and Alzheimer Disease
Article | Year |
---|---|
Antioxidative and antiapoptosis: Neuroprotective effects of dauricine in Alzheimer's disease models.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Animals, Genetically Modified; Antioxidants; Apoptosis; Benzylisoquinolines; Caenorhabditis elegans; Cell Line; Copper; Disease Models, Animal; Humans; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Tetrahydroisoquinolines | 2020 |
Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Cell Line; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Graphite; Humans; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Neuroglia; Oxidative Stress; Particle Size; Reactive Oxygen Species; Superoxide Dismutase; Surface Properties; Tetrahydroisoquinolines | 2021 |
Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans Model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzylisoquinolines; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carrier Proteins; Disease Models, Animal; Neuroprotective Agents; Peptide Fragments; Proteolysis; Signal Transduction; Tetrahydroisoquinolines; Unfolded Protein Response | 2018 |